Table 1.
General data in HRT cycles versus tamoxifen in combination with HRT cycles.
| HRT | TMXF-HRT | P value | |
|---|---|---|---|
| Number (n) | 278 | 187 | |
| Female age (years) | 33.6 ± 4.6 | 32.9 ± 4.2 | 0.089 |
| BMI | 22.78 ± 3.00 | 22.64 ± 3.06 | 0.622 |
| FSH | 7.90 ± 2.90 | 7.58 ± 3.20 | 0.264 |
| AMH | 3.35 ± 4.51 | 3.01 ± 2.48 | 0.344 |
| AFC | 15.7 ± 7.8 | 16.6 ± 7.5 | 0.249 |
| Infertility duration (years) | 3.4 ± 2.6 | 3.1 ± 2.0 | 0.193 |
| Infertility type (primary/secondary) | 90/188 | 56/131 | 0.583 |
| E2 (pg/mL) | 1268.62 ± 1165.03 | 1225.94 ± 965.65 | 0.679 |
| P (ng/mL) | 0.28 ± 0.53 | 0.15 ± 0.25 | 0.002 |
| Em (mm) | 7.00 ± 0.61 | 7.99 ± 1.32 | <0.001 |
| Different Em groups | N/A | ||
| ≤ 6 mm | 35 (12.59%) | 12 (6.42%) | |
| > 6 mm, ≤ 7 mm | 114 (41.00%) | 41 (21.92%) | |
| > 7 mm, ≤ 8 mm | 120 (43.17%) | 53 (28.34%) | |
| > 8 mm | 9 (3.24%) | 81 (43.32%) | |
| Change in Em (mm) | -0.33 ± 1.07 | 1.23 ± 1.16 | <0.001 |
FSH, follicle-stimulating hormone; AFC, antral follicle count; AMH, anti-mullerian hormone; BMI, body mass index; E2, estrogen (before endometrial transformation); P, progesterone (before endometrial transformation); Em, endometrial thickness.